Skip to main content

Long-Term, Open-Label Extension Study to Evaluate the Safety and Tolerability of NBI-827104 in Pediatric Subjects with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep

Clinical Trial Grant
Duke Scholars

Administered By

Pediatrics, Neurology

Awarded By

Neurocrine Biosciences, Inc.

Start Date

May 20, 2022

End Date

August 5, 2024
 

Administered By

Pediatrics, Neurology

Awarded By

Neurocrine Biosciences, Inc.

Start Date

May 20, 2022

End Date

August 5, 2024